Breast cancer drug trastuzumab induces cardiac toxicity: evaluation of human epidermal growth factor receptor 2 as a potential diagnostic and prognostic marker
Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer | Semantic Scholar
View Image
Anti-HER2 therapy in metastatic breast cancer: many choices and future directions | SpringerLink
IJMS | Free Full-Text | Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast Cancer | HTML
Trastuzumab Overview - Creative Biolabs
Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer | Oncotarget
Resistant mechanism to trastuzumab. (1) Steric effects or masking of... | Download Scientific Diagram
Herceptin: mechanisms of action and resistance - ScienceDirect
Pertuzumab and Its Accelerated Approval: Evolving Treatment Paradigms and New Challenges in the Management of HER2-Positive Breast Cancer
Trastuzumab — Mechanism of Action and Use in Clinical Practice | NEJM
What is the mechanism of action of trastuzumab? - Quora
Schematic representation of the mechanism of action of trastuzumab... | Download Scientific Diagram
Herceptin - Mechanism of Action - Proteopedia, life in 3D
Precision medicine and personalized breast cancer: combination pertuzu | PGPM
Figure 2: Mechanism of Action of Trastuzumab and Pathogenesis of its Cardiotoxicity | Radcliffe Cardiology
Targeted treatments of HER2-positive metastatic breast cancer: trastuzumab and beyond | Breast Cancer Management
Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer - Annals of Oncology
Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancer | Future Oncology
Herceptin® (trastuzumab) for HER2+ Cancer
Trastuzumab emtansine: mechanisms of action and drug resistance | Breast Cancer Research | Full Text
